Related Experiment Video
Updated: Jun 16, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Th2-polarisation of cellular immune memory to neonatal pertussis vaccination
Olivia J White1, Julie Rowe, Peter Richmond
1Telethon Institute for Child Health Research, and Centre for Child Health Research, Faculty of Medicine and Dentistry, The University of Western Australia, Perth, Australia.
Insights
Neonatal pertussis vaccination elicits earlier antibody responses but may skew T-cell memory towards a Th2 bias. Further research is needed to assess the clinical impact of early acellular pertussis (aP) vaccination in infants.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Current infant pertussis vaccination (diphtheria, tetanus, acellular pertussis - DTaP) is administered at 2, 4, and 6 months.
- Early infant protection via neonatal vaccination is being explored.
- Concerns exist regarding potential Th2-biased T-cell responses with early pertussis vaccination.
Purpose of the Study:
- To evaluate the immunological impact of neonatal vaccination with a monovalent acellular pertussis vaccine (aP).
- To compare Th-cell memory profiles and antibody responses in infants receiving early aP vaccination versus standard DTaP schedules.
Main Methods:
- A pilot study compared infants receiving aP at birth or birth and 1 month, followed by DTaP, against a control group receiving DTaP from 2 months.
- Pertussis-specific IgG levels were measured at 2, 4, 6, and 8 months.
- In vitro Th-memory responses were assessed at 8 months.
Main Results:
- Neonatal aP vaccination led to earlier pertussis-specific IgG responses.
- Th-memory profiles in neonatally vaccinated infants showed a significant Th2 bias, indicated by high IL-5 and IL-13 production.
- The study involved a small number of infants.
Conclusions:
- Neonatal vaccination with aP can induce earlier antibody responses.
- Early pertussis vaccination may result in a Th2-polarized T-cell memory response.
- Larger trials are necessary to investigate the correlation between these T-cell profiles and clinical outcomes in neonatal aP vaccine studies.
Abstract:
Current infant vaccination against pertussis in North America and Australia requires three doses of vaccines including diphtheria, tetanus and acellular pertussis antigens (DTaP) at 2, 4 and 6 months of age. Interest is growing in the possibility that vaccination at birth might provide earlier protection of infants, but early vaccination also gives rise to concerns over the potential for excessive Th2-polarisation of pertussis-specific T-cell memory profiles. We evaluated this issue as part of a small pilot study comparing infants receiving a monovalent acellular pertussis vaccine (aP) at birth or birth and at 1 month, followed by DTaP at 2, 4 and 6 months with infants receiving DTaP only from 2 months. We compared in vitro Th-memory responses at 8 months and pertussis-specific IgG in serum at 2, 4, 6 and 8 months. Neonatal vaccination elicited earlier IgG responses, but accompanying Th-memory profiles displayed a strong Th2 bias with high IL-5 and IL-13 production. The correlation between T-cell memory profiles and other clinical outcomes should be evaluated in larger trials of neonatal aP vaccine.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

